Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · CIOC 2027

Vasoproliferative Retinal Tumors at CIOC 2027

Part of the CIOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Vasoproliferative Retinal Tumors Session

Vasoproliferative retinal tumors (VPRTs) are rare benign growths that arise from the retina, the light-sensitive tissue at the back of the eye. These tumors typically manifest as small, pinkish masses and can cause vision disturbances or even vision loss if they grow large enough to affect the central visual field. While VPRTs are not malignant, they can still pose significant challenges to vision and quality of life. Treatment options vary depending on the size and location of the tumor, ranging from observation to laser therapy or surgical intervention. Recent advancements in imaging techniques, such as optical coherence tomography (OCT) and fluorescein angiography, have improved our ability to diagnose and monitor VPRTs, leading to more personalized and effective treatment strategies. Ongoing research aims to further understand the underlying mechanisms driving VPRT development and to explore novel targeted therapies that can improve outcomes for affected individuals.

Topics Covered in Vasoproliferative Retinal Tumors

Topic 01

Primary & Secondary Forms

Topic 02

Exudative Retinopathy

Topic 03

Macular Edema

Topic 04

Angiographic Features

Topic 05

Cryotherapy

Topic 06

Photodynamic Therapy

Related Scientific Sessions at CIOC 2027

Why Attend the Vasoproliferative Retinal Tumors Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Vasoproliferative Retinal Tumors work, reviewed by the scientific committee.

Network Globally

Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Vasoproliferative Retinal Tumors research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join CIOC 2027 for the Vasoproliferative Retinal Tumors track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Vasoproliferative Retinal Tumors Conference 2027 — FAQs

What is the Vasoproliferative Retinal Tumors track at CIOC 2027?

The Vasoproliferative Retinal Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Vasoproliferative Retinal Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Vasoproliferative Retinal Tumors sessions?

Cancer researchers and clinicians, educators and students with an interest in Vasoproliferative Retinal Tumors are all welcome — whether presenting or attending.

Can I present my research in the Vasoproliferative Retinal Tumors track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Vasoproliferative Retinal Tumors sessions?

Yes. CIOC 2027 is a hybrid conference — attend the Vasoproliferative Retinal Tumors track in person in Singapore or join live online, with on-demand access afterward.

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us